Skip to content

Clinical trials

Carcinoid Tumor trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoid Tumor Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20042
20053
20067
20071
20087
20097
20108
20114
20122
20134
20144
201510
20163
20172
20184
20194
20201
20213
20227
20231
20241
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Unknown status13
Terminated10
Recruiting9
Active, not recruiting8
Withdrawn7
No longer available3
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Dana-Farber Cancer Institute7
British Columbia Cancer Agency4
H. Lee Moffitt Cancer Center and Research Institute4
Suez Canal University3
CHU de Reims2
Crinetics Pharmaceuticals Inc.2
Hospices Civils de Lyon2
M.D. Anderson Cancer Center2
RayzeBio, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoid Tumor100
Neuroendocrine Tumors57
Adenoma, Islet Cell15
Neoplasms12
Neoplasm Metastasis11
Neuroblastoma9
Pheochromocytoma9
Paraganglioma8
Serotonin Syndrome8
Carcinoma7

Trials

Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.